Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Foundation Fighting Blindness Retinal Degeneration Insider Profile

4 Followers

Foundation Fighting Blindness Retinal Degeneration, Director, See Remarks at Opus Genetics, holds 3.79M shares in Opus Genetics (Ticker: IRD). Most recently, Foundation Fighting Blindness Retinal Degeneration Sold 1,700,000 shares of Opus Genetics on May 20, 2026 for an estimated value of $7.39M.

Foundation Fighting Blindness Retinal Degeneration's Trading History

IRDOpus Genetics		May 20, 2026Director, See RemarksInformative Sell7.39M$13.92M
IRD
Insider Shares: 3.79M (4.66%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 20, 2026Informative Sell$7.39M1,700,000$4.35+17.30%
Dec 11, 2025Informative Sell$8.60M4,000,000$2.15-50.40%
May 06, 2025Uninformative Buy$0.006,927,419$0.00―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Foundation Fighting Blindness Retinal Degeneration insider profile FAQ

What is the percentage of profitable transactions made by Foundation Fighting Blindness Retinal Degeneration?
The percentage of profitable transactions made by Foundation Fighting Blindness Retinal Degeneration is 50%.
What is the average return per transaction made by Foundation Fighting Blindness Retinal Degeneration?
The average return per transaction made by Foundation Fighting Blindness Retinal Degeneration is -16.50%.
What stocks does Foundation Fighting Blindness Retinal Degeneration hold?
Foundation Fighting Blindness Retinal Degeneration holds: IRD stocks.
What was Foundation Fighting Blindness Retinal Degeneration’s latest transaction?
Foundation Fighting Blindness Retinal Degeneration’s latest transaction was an Informative Sell of $7.39M.
What was Foundation Fighting Blindness Retinal Degeneration's most profitable transaction?
Foundation Fighting Blindness Retinal Degeneration’s most profitable transaction was an Informative Sell of IRD stock on May 20, 2026. The return on the trade was 17.30%.
What is Foundation Fighting Blindness Retinal Degeneration's role in Opus Genetics?
Foundation Fighting Blindness Retinal Degeneration's role in Opus Genetics is Director, See Remarks.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.